Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human NMB Protein, N-GST

Catalog #:   YHC37501 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P08949
Protein length: Ala25-Lys121
Overview

Catalog No.

YHC37501

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ala25-Lys121

Predicted molecular weight

37.66 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P08949

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

NMB, Neuromedin-B

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human NMB protein
References

Exploration of the utilization of irreversible cysteine protease inhibitor in FAP-targeted radiopharmaceuticals design to increase tumor residence time., PMID:40499303

NMB promotes the progression of colorectal cancer by regulating the NF-κB/P65 signaling pathway., PMID:40486508

Gestational fish oil supplementation in high-fat diet induces sex-specific myokine changes in weanling offspring., PMID:40459971

Carbon-11-labelling of the histone deacetylase 6 radioligand EKZ-001., PMID:40424693

Comprehensive genetic analysis based on multi - omics reveals novel therapeutic targets for mitral valve prolapse and drug molecular dynamics simulation., PMID:40311696

Gene mapping and identification of candidate genes controlling carotenoid accumulation of yellow kernels in foxtail millet., PMID:40281394

Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy., PMID:40253776

GPNMB Suppresses Inflammation and Extracellular Matrix Degradation in Nucleus Pulposus Cells by Inhibiting Pro-Inflammatory Cytokine Production and Activation of the NF-κB Signaling Pathway., PMID:40234039

Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans., PMID:40179687

Characterization of Canadian Neisseria meningitidis serogroup B isolates and factor-H binding protein expression, data from the Canadian Immunization Monitoring Program Active (IMPACT), 2013-2020., PMID:40163976

Discovery and functional characterization of a bombesin-type neuropeptide signaling system in an invertebrate., PMID:40153458

Fluctuations in serogroup B meningococcal vaccine antigens prior to routine MenB vaccination in France., PMID:40133410

Evidence Showing Bombesin-Like Peptides Contract Guinea Pig Vas Deferens Smooth Muscle., PMID:40128924

Recurrent polypoidal lesions after achieving inactive polypoidal choroidal vasculopathy following 1-year fixed-dosing aflibercept treatments., PMID:40032076

Optimization and scale-up of [68Ga]Ga-FAPI-46 production on a Modular-Lab PharmTracer platform for clinical application., PMID:39999572

Investigating the fate of Zirconium-89 labelled antibody in cynomolgus macaques., PMID:39985867

Longitudinal multi-tracer imaging of hepatocellular carcinoma identifies novel stage- and oncogene-specific changes., PMID:39970776

First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparaginate, [18F]RP-115., PMID:39913962

A Markov model assessing the cost-effectiveness of various anti-vascular endothelial growth factor drugs and panretinal photocoagulation for the treatment of proliferative diabetic retinopathy., PMID:39910280

[18F]BCPP-EF positron emission tomography of rat ovaries for evaluation of mitochondrial function., PMID:39862603

Characterization of a novel PET radioligand for mitochondrial complex I in nonhuman primate., PMID:39824008

Cost-effectiveness analysis of PD-L1 testing associated with pembrolizumab for first-line treatment of advanced non-small cell lung cancer in China., PMID:39804416

Blockade of PVN neuromedin B receptor alleviates inflammation via the RAS/ROS/NF-κB pathway in spontaneously hypertensive rats., PMID:39716597

Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus., PMID:39647268

Circulating Protein and Metabolite Correlates of Histologically Confirmed Diabetic Kidney Disease., PMID:39634330

Revealing potential drug targets in schizophrenia through proteome-wide Mendelian randomization genetic insights., PMID:39615872

Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer., PMID:39615062

225Aс/213Bi generator for direct synthesis of 213Bi-labeled bioconjugates., PMID:39603113

New prospects for 89Zr-immuno-PET in brain applications - Alpha-synucleinopathies., PMID:39591759

Convection-enhanced delivery of [177Lu]Lu-labeled gold nanoparticles combined with anti-PD1 checkpoint immunotherapy improves the survival of immunocompetent C57BL/6J mice with orthotopic GL261 murine glioma tumors., PMID:39571483

Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework., PMID:39520611

Senescent Syncytiotrophoblast Secretion During Early Onset Preeclampsia., PMID:39440423

Antimicrobial peptide LyeTx I mn∆K labeled with 68Ga is a potential PET radiopharmaceutical for molecular imaging of infections., PMID:39426352

Influence of PEGylation on HER2-targeting retro A9 peptide analogue., PMID:39383591

Hypoxia-Associated GPNMB+ Macrophages Promote Malignant Progression of Colorectal Cancer and Its Related Risk Signature Are Powerful Predictive Tool for the Treatment of Colorectal Cancer Patients., PMID:39367576

Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM26., PMID:39357076

Secretion of GPNMB from Neural Stem Cells Induced by ET-1 Contributes to Angiogenesis after Spinal Cord Injury., PMID:39327246

Towards imaging the immune state of cancer by PET: Targeting legumain with 11C-labeled P1-Asn peptidomimetics carrying a cyano-warhead., PMID:39303441

Effect of Non-Meat Proteins on Storage Characteristics and Amino Acid Composition of Pork Emulsified Sausages., PMID:39246547

Cervical cancer-produced neuromedin-B reprograms Schwann cells to initiate perineural invasion., PMID:39214988

Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension., PMID:39162036

Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders., PMID:39153354

Preclinical investigation of the effect of stress on the binding of [18F]F13640, a 5-HT1A radiopharmaceutical., PMID:39151306

Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages., PMID:39151305

Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study., PMID:39097500

Seasonal Proteome Variations in Orbicella faveolata Reveal Molecular Thermal Stress Adaptations., PMID:39051238

Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding., PMID:39038609

The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects., PMID:39033550

Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen., PMID:39032262

Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip., PMID:39012102

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human NMB Protein, N-GST [YHC37501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only